Vascular endothelial growth factor inhibitors in exudative retinal diseases: overview of recent advances and prospects for further progress
Year: 2024
Type: article
Abstract: The incidence of blindness due to exudative retinal diseases reduced significantly over the twenty years of the use of anti-vascular endothelial growth factor (VEGF) therapy in ophthalmology. However, despite advances in recent years, current outcomes of anti-VEGF therapy for exudative retinal diseases are not always optimal. This review aims to highlight the advances in the development of VEGF inhibitors and identify potential ways of improving the outcomes of anti-VEGF therapy for, and solving current problems in the management of, exudative retinal diseases.
Source: Oftalmologicheskii Zhurnal
Authors: G. V. Zaychenko, V. P. Rozumnyi
Institution: Bogomolets National Medical University
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4401842704